These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18685105)

  • 1. Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation.
    Kotti T; Head DD; McKenna CE; Russell DW
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11394-9. PubMed ID: 18685105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain cholesterol turnover required for geranylgeraniol production and learning in mice.
    Kotti TJ; Ramirez DM; Pfeiffer BE; Huber KM; Russell DW
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3869-74. PubMed ID: 16505352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation.
    Mans RA; McMahon LL; Li L
    Neuroscience; 2012 Jan; 202():1-9. PubMed ID: 22192838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
    Fisher JE; Rogers MJ; Halasy JM; Luckman SP; Hughes DE; Masarachia PJ; Wesolowski G; Russell RG; Rodan GA; Reszka AA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):133-8. PubMed ID: 9874784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin Enhances Spatial Memory and Long-Term Potentiation in Hippocampal CA1 via Upregulation of α7 Nicotinic Acetylcholine Receptor.
    Chen T; Wang C; Sha S; Zhou L; Chen L; Chen L
    Mol Neurobiol; 2016 Aug; 53(6):4060-4072. PubMed ID: 26198568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells.
    Crick DC; Andres DA; Waechter CJ
    Biochem Biophys Res Commun; 1995 Jun; 211(2):590-9. PubMed ID: 7794274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.
    Kothapalli R; Guthrie N; Chambers AF; Carroll KK
    Lipids; 1993 Nov; 28(11):969-73. PubMed ID: 8277827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras inhibitor S-trans, trans-farnesylthiosalicylic acid enhances spatial memory and hippocampal long-term potentiation via up-regulation of NMDA receptor.
    Wang Y; Chen T; Yuan Z; Zhang Y; Zhang B; Zhao L; Chen L
    Neuropharmacology; 2018 Sep; 139():257-267. PubMed ID: 29578035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Mevalonate Pathway in Cancer.
    Juarez D; Fruman DA
    Trends Cancer; 2021 Jun; 7(6):525-540. PubMed ID: 33358111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells.
    Crick DC; Andres DA; Danesi R; Macchia M; Waechter CJ
    J Neurochem; 1998 Jun; 70(6):2397-405. PubMed ID: 9603204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for farnesol-mediated isoprenoid synthesis regulation in a halophilic archaeon, Haloferax volcanii.
    Tachibana A; Tanaka T; Taniguchi M; Oi S
    FEBS Lett; 1996 Jan; 379(1):43-6. PubMed ID: 8566226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesol and geranylgeraniol: prevention and reversion of lovastatin-induced effects in NIH3T3 cells.
    Ownby SE; Hohl RJ
    Lipids; 2002 Feb; 37(2):185-92. PubMed ID: 11908910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient use of exogenous isoprenols for protein isoprenylation by MDA-MB-231 cells is regulated independently of the mevalonate pathway.
    Onono F; Subramanian T; Sunkara M; Subramanian KL; Spielmann HP; Morris AJ
    J Biol Chem; 2013 Sep; 288(38):27444-27455. PubMed ID: 23908355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hippocampal long-term potentiation in microtubule-associated protein 1B-deficient mice.
    Zervas M; Opitz T; Edelmann W; Wainer B; Kucherlapati R; Stanton PK
    J Neurosci Res; 2005 Oct; 82(1):83-92. PubMed ID: 16118800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells.
    Miquel K; Pradines A; Favre G
    Biochem Biophys Res Commun; 1996 Aug; 225(3):869-76. PubMed ID: 8780704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol inhibits long-term potentiation in hippocampal CA1 neurons, irrespective of lamina and stimulus strength, through neurosteroidogenesis.
    Ramachandran B; Ahmed S; Zafar N; Dean C
    Hippocampus; 2015 Jan; 25(1):106-18. PubMed ID: 25155179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain.
    Russell DW; Halford RW; Ramirez DM; Shah R; Kotti T
    Annu Rev Biochem; 2009; 78():1017-40. PubMed ID: 19489738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells.
    Miquel K; Pradines A; Tercé F; Selmi S; Favre G
    J Biol Chem; 1998 Oct; 273(40):26179-86. PubMed ID: 9748300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. v-K-ras leads to preferential farnesylation of p21(ras) in FRTL-5 cells: multiple interference with the isoprenoid pathway.
    Laezza C; Di Marzo V; Bifulco M
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13646-51. PubMed ID: 9811854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.